Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kalaycio

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Leukemia|February 20, 2003
Treatment of relapsed or refractory acute myeloid leukemia with humanized anti-CD33 monoclonal antibody HuM195E Feldman, M Kalaycio, G Weiner, et al.
Bone Marrow Transplantation|June 11, 2013
Long-term follow-up of a prospective randomized trial comparing CYA and MTX with CYA and mycophenolate mofetil for GVHD prophylaxis in myeloablative sibling donor hematopoietic cell transplantationB K Hamilton, B Bolwell, M Kalaycio, et al.
Bone Marrow Transplantation|January 11, 2005
Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical courseR Avery, M Kalaycio, B Pohlman, et al.
Bone Marrow Transplantation|May 19, 2010
Comparison of outcomes after auto-SCT for patients with relapsed diffuse large B-cell lymphoma according to previous therapy with rituximabS D Smith, B J Bolwell, L A Rybicki, et al.
Bone Marrow Transplantation|May 29, 2007
Autologous hematopoietic stem cell transplantation in peripheral T-cell lymphoma using a uniform high-dose regimenS D Smith, B J Bolwell, L A Rybicki, et al.
Bone Marrow Transplantation|February 21, 2007
Survival of AML patients receiving HLA-matched sibling donor allogeneic bone marrow transplantation correlates with HLA-Cw ligand groups for killer immunoglobulin-like receptorsR M Sobecks, E J Ball, J P Maciejewski, et al.
Bone Marrow Transplantation|October 26, 2005
Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survivalR Dean, P Masci, B Pohlman, et al.
Bone Marrow Transplantation|April 5, 2011
Etoposide plus G-CSF priming compared with G-CSF alone in patients with lymphoma improves mobilization without an increased risk of secondary myelodysplasia and leukemiaA Mahindra, B J Bolwell, L Rybicki, et al.
Blood Cancer Journal|August 29, 2015
Does day 11 omission of methotrexate due to toxicity influence the outcome in myeloablative hematopoietic cell transplant? Results from a single-center retrospective cohort studyB K Hamilton, L Rybicki, H Haddad, et al.
Bone Marrow Transplantation|January 25, 2011
Apheresis days required for harvesting CD34+ cells predicts hematopoietic recovery and survival following autologous transplantationS Malik, B Bolwell, L Rybicki, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Leukemia|February 20, 2003
Treatment of relapsed or refractory acute myeloid leukemia with humanized anti-CD33 monoclonal antibody HuM195E Feldman, M Kalaycio, G Weiner, et al.
Bone Marrow Transplantation|June 11, 2013
Long-term follow-up of a prospective randomized trial comparing CYA and MTX with CYA and mycophenolate mofetil for GVHD prophylaxis in myeloablative sibling donor hematopoietic cell transplantationB K Hamilton, B Bolwell, M Kalaycio, et al.
Bone Marrow Transplantation|January 11, 2005
Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical courseR Avery, M Kalaycio, B Pohlman, et al.
Bone Marrow Transplantation|May 19, 2010
Comparison of outcomes after auto-SCT for patients with relapsed diffuse large B-cell lymphoma according to previous therapy with rituximabS D Smith, B J Bolwell, L A Rybicki, et al.
Bone Marrow Transplantation|May 29, 2007
Autologous hematopoietic stem cell transplantation in peripheral T-cell lymphoma using a uniform high-dose regimenS D Smith, B J Bolwell, L A Rybicki, et al.
Bone Marrow Transplantation|February 21, 2007
Survival of AML patients receiving HLA-matched sibling donor allogeneic bone marrow transplantation correlates with HLA-Cw ligand groups for killer immunoglobulin-like receptorsR M Sobecks, E J Ball, J P Maciejewski, et al.
Bone Marrow Transplantation|October 26, 2005
Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survivalR Dean, P Masci, B Pohlman, et al.
Bone Marrow Transplantation|April 5, 2011
Etoposide plus G-CSF priming compared with G-CSF alone in patients with lymphoma improves mobilization without an increased risk of secondary myelodysplasia and leukemiaA Mahindra, B J Bolwell, L Rybicki, et al.
Blood Cancer Journal|August 29, 2015
Does day 11 omission of methotrexate due to toxicity influence the outcome in myeloablative hematopoietic cell transplant? Results from a single-center retrospective cohort studyB K Hamilton, L Rybicki, H Haddad, et al.
Bone Marrow Transplantation|January 25, 2011
Apheresis days required for harvesting CD34+ cells predicts hematopoietic recovery and survival following autologous transplantationS Malik, B Bolwell, L Rybicki, et al.
Pageof 7